TAMEST Conference to Feature Program on Cancer Research and Treatment

Share Article

The 12th annual conference—Cancer: A Texas Sized Problem—of The Academy of Medicine, Engineering & Science of Texas (TAMEST) will explore the epidemiology, genetics, initiation, progression, and treatment paradigms of perhaps the most pressing current health problem of our society—CANCER.

TAMEST Logo
“Only by a sustained and integrated full-frontal attack from individual investigators, investigator teams, and national cooperative studies can we hope to make a sizable dent in this dreaded disease,” said Bert W. O'Malley, M.D., conference program chair.

The Academy of Medicine, Engineering & Science of Texas (TAMEST) will hold its 12th annual conference—Cancer: A Texas-Sized Problem—January 22-23, 2015, at the Omni Houston Hotel in Houston, Texas. The conference program will explore the epidemiology, genetics, initiation, progression, and treatment paradigms of perhaps the most pressing current health problem of our society—CANCER.

Thursday’s program will feature keynote addresses by James P. Allison, Ph.D., The University of Texas MD Anderson Cancer Center; Margaret L. Kripke, Ph.D., Cancer Prevention and Research Institute of Texas; and Mike Pazin, Ph.D., National Institutes of Health. Friday’s program will include keynote speakers Judith A. Salerno, M.D., M.S., Susan G. Komen®, and Frederic de Sauvage, Ph.D., Genentech, Inc.

The conference will also include a dinner on Thursday, January 22 to honor the recipients of the 2015 Edith and Peter O’Donnell Awards, which recognize rising Texas researchers who are addressing the essential role that science and technology play in society, and whose work meets the highest standards of exemplary professional performance, creativity, and resourcefulness. For more information about the 2015 O’Donnell Awards recipients, please visit http://www.tamest.org/programs/2015-recipients.html.

“Although the last two decades have generated important new insights for the field of oncology, ‘cures’ are still few in number,” said Bert W. O'Malley, M.D., professor and chairman, Molecular and Cellular Biology at Baylor College of Medicine and program chair. “Only by a sustained and integrated full-frontal attack from individual investigators, investigator teams, and national cooperative studies can we hope to make a sizable dent in this dreaded disease.”

For further information, please visit http://www.tamest.org/events/2015-annual-conference.html.

About TAMEST
TAMEST is what comes before the change you see in our state. A nonprofit and a brain trust for Texas, TAMEST convenes influential experts to promote cross-industry and cross-disciplinary knowledge sharing. Through TAMEST, research collides with industry. Our members make new discoveries, lay the groundwork for tackling critical issues, and change the course of funding, legislation, and society. With 270+ members, TAMEST is composed of the Texas-based members of the three National Academies (Institute of Medicine, National Academy of Engineering, and National Academy of Sciences) and the state’s 10 Nobel Laureates. TAMEST brings the state’s top scientific, academic, and corporate minds together to further position Texas as a national research leader. TAMEST also fosters the next generation of scientists and facilitates awareness and communication among the state’s best and brightest about research priorities for the future. More information is available at http://www.tamest.org.

Share article on social media or email:

View article via:

Pdf Print